Related Experiment Video
Updated: Nov 23, 2025

10:25
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
5.0K
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
S A Kemp1, D A Collier1,2,3, R Datir1,2,3
1Division of Infection and Immunity, University College London, London, UK.
Medrxiv : the Preprint Server for Health Sciences
|January 5, 2021
Summary
SARS-CoV-2 variants with reduced antibody sensitivity emerged during convalescent plasma treatment in an immunocompromised patient. These viral escape mutations highlight selection pressures and potential therapeutic challenges.
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) Spike protein facilitates viral entry by binding to Angiotensin-Converting Enzyme 2 (ACE2).
- Amino acid variations in the Spike protein are increasingly recognized, raising concerns about potential viral escape from vaccines and therapeutics, especially in immunocompromised individuals with prolonged viral replication.
Conclusions:
- Convalescent plasma therapy exerts strong selection pressure on SARS-CoV-2, driving the emergence of variants with reduced susceptibility to neutralizing antibodies.
- The observed mutations, particularly ΔH69/ΔV70 and D796H in the Spike protein, confer an antibody escape phenotype.
- These findings underscore the potential for viral evolution during therapeutic interventions and highlight the need to monitor for emerging SARS-CoV-2 variants.
Related Concept Videos
Cross-reactivity
32.1K
Overview
32.1K
Humoral Immune Responses
80.7K
Overview
80.7K
Immune Response Against Viral Pathogens
1.3K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.3K
Antibody Actions
1.8K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.8K
B Cell Activation and Differentiation
15.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.2K

